Study of ZKAB001 for Maintenance Therapy in Patients With High-grade Osteosarcoma After Adjuvant Chemotherapy

NCT04359550 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

362

Enrollment

INDUSTRY

Sponsor class

Conditions

High-grade Osteosarcoma

Interventions

BIOLOGICAL: Recombinant human anti-PD-L1 monoclonal antibody (ZKAB001)
OTHER: placebo

Sponsor

Lee's Pharmaceutical Limited